BM |
Bacterial meningitis |
CNS |
Central nervous system |
BBB |
Blood-brain barrier |
GBS |
Group B Streptococcus |
HIV |
Human immunodeficiency virus |
CM |
Cryptococcal meningitis |
HiB |
Haemophilus influenzae |
MIC |
Minimum inhibitory concentration |
TNF-α |
Tumor necrosis factor-α |
TLR |
Toll-like receptors |
IL-1α |
Interleukin-1α |
NLRs |
Nod-like receptors |
LPS |
Lipopolysaccharides |
PAMPs |
Pathogen-associated molecular patterns |
NF-κ B |
Nuclear factor kappa B |
MAPK |
Mitogen-activation protein kinase |
PBN |
Phenyl N-t-butylnitrone |
4-HNE |
4-Hydroxynonenal |
MDA |
Malondialdehyde |
iNOS |
inducible Nitric Oxide Synthase |
HBMEC |
Human Brain Microvascular Endothelial Cell |
IL-6 |
Interleukin-6 |
ROS |
Reactive oxygen species |
RNS |
Reactive nitrogen species |
MMPs |
Matrix metalloproteinases |
CSF |
Cerebrospinal fluid |
BMECs |
Brain microvascular endothelial cells |
AJs |
Adherens junctions |
TJs |
Tight junctions |
ZO-1 |
Zonula occluding-1 |
CSF |
Cerebrospinal fluid |
SOD |
Superoxide dismutase |
PMN |
Polymorphonuclear |
mTOR |
Mammalian target of rapamycin |
Bmal 1 |
Brain and muscle Arnt-like protein 1 |
FAK |
Focal Adhesion Kinase |
LP |
Lactate/pyruvate |
MyD88 |
Myeloid differentiation factor 88 |
ERK1/2 |
Extracellular signal-related kinases 1/2 |
EGFR |
Epidermal growth factor receptor |
AFMK |
N1-acetyl-N2-formyl-5-methoxykynuramine |
PCV |
Pneumococcal conjugate vaccines |
PPV |
Pneumococcal polysaccharide vaccine |
PspA |
Pneumococcal surface protein |
Ply |
Pneumolysin |